Press Releases
-
SK bioscience donated to support the local community where L House, SK bioscience’s vaccine manufact...2023.07.31 -
SK bioscience identified 11 top-priority issues by adopting Double Materiality Assessment. Company e...2023.07.28 -
-Jaeyong Ahn, the CEO of SK bioscience, virtually joined the WHO workshop with representatives of gl...2023.07.13 -
SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response...2023. 07. 05 -
-The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates...2023.06.30 -
SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the P...2023.06.27 -
- In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 ...2023.06.19 -
The MHRA’s Marketing Authorization for SK bioscience COVID-19 vaccine is valid in the United Kingdom...2023.05.30 -
Jaeyong Ahn, CEO of SK bioscience presented the ‘Glocalization’ project to secure the vaccine access...2023.05.23 -
The vaccine will be manufactured at L HOUSE, SK bioscience’s vaccine manufacturing plant.“We will co...2023.05.08 -
SK bioscience-The International Vaccine Institute(IVI) jointly announce winners of the second Park M...2023.03.07 -
- ‘SKYZoster®, ´ the world second developed herpes zoster vaccine secures 54% of the South Korean ma...2023. 02. 28